- Report
- March 2020
- 236 Pages
Global
From €3436EUR$3,600USD£2,879GBP
- Report
- December 2021
- 156 Pages
Global
From €3818EUR$4,000USD£3,199GBP
- Report
- April 2024
- 80 Pages
Argentina
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
Brazil
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
China
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
France
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
Germany
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
India
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
Ireland
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
Japan
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
Poland
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
Russia
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
Saudi Arabia
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
South Korea
From €1432EUR$1,500USD£1,199GBP
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
United Kingdom
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
Vietnam
From €1432EUR$1,500USD£1,199GBP
- Report
- October 2023
- 177 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- October 2023
- 97 Pages
Global
From €2815EUR$2,950USD£2,359GBP
- Report
- October 2023
- 94 Pages
Middle East, Africa
From €2815EUR$2,950USD£2,359GBP

Inhalers and nebulisers are medical devices used to deliver medication to the lungs. Inhalers are handheld devices that deliver medication in the form of a mist or aerosol, while nebulisers are larger machines that deliver medication in the form of a fine mist. Inhalers are the most common form of medication delivery for respiratory conditions such as asthma and COPD.
Inhalers and nebulisers are used by millions of people around the world, and the market for these devices is highly competitive. Companies in the market are constantly innovating to develop new and improved devices that are more effective and easier to use. Many of these devices are now available over the counter, making them more accessible to patients.
The inhaler market is also highly regulated, with governments and health authorities setting standards for the safety and efficacy of these devices. Companies must adhere to these standards in order to remain competitive.
Some of the major companies in the inhaler market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, Merck, and Teva Pharmaceuticals. Show Less Read more